期刊文献+

高品质碳酸镧晶簇的合成与表征

Synthesis and characterization of high medicinal value lanthanum carbonate with a layer-crystal structure
下载PDF
导出
摘要 目的合成高品质的碳酸镧晶簇,并对合成的样品进行表征.方法采用碳酸氢钠与氯化镧反应,通过控制体系pH值,并添加一定量的乙醇,合成了高品质的碳酸镧.采用X射线衍射、傅里叶红外光谱、扫描电镜以及热重分析等分析方法对合成的样品进行了表征.结果结果表明,通过添加乙醇可以得到层状的碳酸镧晶簇,其晶簇尺寸约为20~50μm,层厚为0.6~0.8μm.结论碳酸镧较高的比表面积更有利于与磷结合,进而降低胃肠道对磷的吸收. Objective To synthesize high medicinal value lanthanum carbonate,and characterize the synthetic sim-ples.Methods Lanthanum carbonate was synthesized by lanthanum chloride and sodium bicarbonate.It can be synthesized by changing synthesis conditions,which include adjusting pH value and adding different additives.Furthermore,the synthet-ic samples were characterized by several techniques including X -ray diffraction (XRD),Fourier transform infrared spec-trometer (FTIR),scanning electron microscopy (SEM),and Thermo gravimetric analyzer (TGA).Results The results showed that layer -crystal was synthesized by adding ethanol in the synthetic systems,and the crytal size was 20 ~50 μm with a layer up to 0.6 ~0.8 μm thick.Conlusion The higher specific surface area of lanthanum carbonate was more fa-vorable to the combination of phosphate,and can reduce the absorption of phosphorus in the gastrointestinal tract.
出处 《药学研究》 CAS 2016年第3期154-156,共3页 Journal of Pharmaceutical Research
关键词 碳酸镧 晶簇 有机溶剂 Lanthanum carbonate Layer-crystal Ethanol
  • 相关文献

参考文献14

二级参考文献87

  • 1高玉春,李孜,唐晓红,刁骧(审校).碳酸镧治疗维持性血液透析患者高磷血症有效性和安全性的系统评价[J].中国循证医学杂志,2006,6(10):727-732. 被引量:12
  • 2Kidney Disease:Improving Global Outcomes(KDIGO)CKDMBD Work Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of Chronic Kidney Disease-Mineral and Bone.
  • 3Disorder(CKD-MBD)[J].Kidney Int,2009(Suppl):S1-130.
  • 4Nikolov IG,Joki N,Maizel J,et al.Pleiotropic effects of the non-calcium phosphate binder sevelamer[J].Kidney Int,2006,105(Suppl):S16-S23.
  • 5John TD,William FF,Michael E,et al.The phosphate binder equivalent dose[J].Semin Dial,2011,24:41-49.
  • 6Goodman WG,Goldin J,Kuizon BD,et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engl J Med,2000,342:1478-1483.
  • 7Guerin AP,London GM,Marchais SJ,et al.Arterial stiffening and vascular calcifications in endstage renal disease[J].Nephrol Dial Transplant,2000,15:1014-1021.
  • 8Cassidy MJ,Owen JP,Ellis HA,et al.Renal osteodystrophy and metastatic calcification in long term continuous ambulatory peritoneal dialysis[J].Q J Med,1985,54:29-48.
  • 9West SL,Swan VJ,Jamal SA.Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population[J].Clin J Am Sac Nephrol,2010,5 (Suppl 1):S41-S47.
  • 10Hutchison AJ,Barnett ME,Krause R,et al.Long-term efficacy and safety profile of lanthanum carbonate:results for up to 6 years of treatment[J].Nephrol Cli Pract,2008,110:15-23.

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部